Source Paper
Source Paper
MF Beal, E Brouillet, BG Jenkins, RJ Ferrante, NW Kowall et al.
Journal of Neuroscience • 1993
An impairment of energy metabolism may underlie slow excitotoxic neuronal death in neurodegenerative diseases. We therefore examined the effects of intrastriatal, subacute systemic, or chronic systemic administration of the mitochondrial toxin 3-nitropropionic acid (3-NP) in rats. Following intrastriatal injection 3-NP produced dose-dependent striatal lesions. Neurochemical and histologic evaluation showed that markers of both spiny projection neurons (GABA, substance P, calbindin) and aspiny interneurons (somatostatin, neuropeptide Y, NADPH- diaphorase) were equally affected. Subacute systemic administration of 3-NP produced age-dependent bilateral striatal lesions with a similar neurochemical profile. However, in contrast to the intrastriatal injections, striatal dopaminergic afferent projections were spared. Both freeze-clamp measurements and chemical shift magnetic resonance spectroscopy showed that 3-NP impairs energy metabolism in the striatum in vivo. Microdialysis showed no increase in extracellular glutamate concentrations after systemic administration of 3-NP. The lesions produced by intrastriatal injection or systemic administration of 3-NP were blocked by prior decortication. However, the NMDA antagonist MK- 801 did not block the effects of intrastriatal 3-NP, consistent with a non-NMDA excitotoxic mechanism. In contrast to subacute systemic administration of 3-NP, chronic (1 month) administration produced lesions confined to the striatum in which there was relative sparing of NADPH-diaphorase interneurons, consistent with an NMDA excitotoxic process. Chronic administration showed growth-related proliferative changes in dendrites of spiny neurons similar to changes in Huntington's disease (HD). These results are consistent with in vitro studies showing that mild metabolic compromise can selectively activate NMDA receptors while more severe compromise activates both NMDA and non- NMDA receptors. Chronic administration of 3-NP over 1 month produces selective striatal lesions that replicate many of the characteristic histologic and neurochemical features of HD.
Objective: To determine the role of cortical input in mediating 3-nitropropionic acid (3-NP)-induced striatal lesions by comparing lesion formation in decorticated versus intact animals
This is a Decortication Study protocol using rat as the model organism. The procedure involves 10 procedural steps, 3 equipment items, 2 materials. Extracted from a 1993 paper published in Journal of Neuroscience.
Model and subjects
rat • Not specified • unknown • Not specified • Not specified
Study window
Estimated timing pending
Core workflow
Prior decortication surgery • Intrastriatal 3-NP injection • Subacute systemic 3-NP administration
Primary readouts
Key equipment and reagents
Verified items
0
Direct vendor links
0
Use this page as an execution guide, then fall back to the source paper whenever you need exact exclusions, dosing details, or assay-specific caveats.
Confirm first
Use the page like this
Start here. The step list is optimized for running the experiment, with direct vendor links available inline when you need to source a cited item.
Perform decortication procedure prior to 3-NP administration to remove cortical input
Note: This is the key manipulation to test cortical involvement in 3-NP-induced lesions
“The lesions produced by intrastriatal injection or systemic administration of 3-NP were blocked by prior decortication”
Administer 3-NP directly into the striatum at varying doses to produce dose-dependent lesions
Note: Produces dose-dependent striatal lesions affecting both spiny projection neurons and aspiny interneurons
“Following intrastriatal injection 3-NP produced dose-dependent striatal lesions”
Administer 3-NP systemically via subacute dosing regimen
Note: Produces age-dependent bilateral striatal lesions with sparing of dopaminergic afferent projections
“Subacute systemic administration of 3-NP produced age-dependent bilateral striatal lesions with a similar neurochemical profile”
Administer 3-NP systemically over extended duration
Note: Produces lesions confined to striatum with relative sparing of NADPH-diaphorase interneurons and growth-related proliferative changes in dendrites
“chronic (1 month) administration produced lesions confined to the striatum in which there was relative sparing of NADPH-diaphorase interneurons”
Administer NMDA antagonist MK-801 to test whether NMDA receptors mediate 3-NP effects
Note: MK-801 did not block intrastriatal 3-NP effects, suggesting non-NMDA excitotoxic mechanism
“the NMDA antagonist MK-801 did not block the effects of intrastriatal 3-NP, consistent with a non-NMDA excitotoxic mechanism”
Measure energy metabolism in striatum using freeze-clamp technique
Note: Demonstrates that 3-NP impairs energy metabolism in vivo
“Both freeze-clamp measurements and chemical shift magnetic resonance spectroscopy showed that 3-NP impairs energy metabolism in the striatum in vivo”
Measure energy metabolism using chemical shift magnetic resonance spectroscopy
Note: Confirms energy metabolism impairment in striatum
“Both freeze-clamp measurements and chemical shift magnetic resonance spectroscopy showed that 3-NP impairs energy metabolism in the striatum in vivo”
Measure extracellular glutamate concentrations using microdialysis
Note: Shows no increase in extracellular glutamate after systemic 3-NP administration
“Microdialysis showed no increase in extracellular glutamate concentrations after systemic administration of 3-NP”
Assess markers of spiny projection neurons (GABA, substance P, calbindin) and aspiny interneurons (somatostatin, neuropeptide Y, NADPH-diaphorase)
Note: Both neuron types equally affected by intrastriatal injection; chronic systemic administration shows relative sparing of NADPH-diaphorase interneurons
“Neurochemical and histologic evaluation showed that markers of both spiny projection neurons (GABA, substance P, calbindin) and aspiny interneurons (somatostatin, neuropeptide Y, NADPH-diaphorase) were equally affected”
Perform histologic examination of striatal lesions and neuronal changes
Note: Chronic administration shows growth-related proliferative changes in dendrites similar to Huntington's disease
“Chronic administration of 3-NP over 1 month produces selective striatal lesions that replicate many of the characteristic histologic and neurochemical features of HD”
This section explains what the experiment is doing, which readouts matter, what the data artifacts usually look like, and how the analysis should flow from raw capture to reported result.
To determine the role of cortical input in mediating 3-nitropropionic acid (3-NP)-induced striatal lesions by comparing lesion formation in decorticated versus intact animals
Objective
To determine the role of cortical input in mediating 3-nitropropionic acid (3-NP)-induced striatal lesions by comparing lesion formation in decorticated versus intact animals
Subjects
From paperrat • Not specified • unknown • Not specified • Not specified
Cohort notes
From paperAge-dependent effects noted in systemic administration studies
Prior decortication surgery (Not specified)
Intrastriatal 3-NP injection (Not specified)
Subacute systemic 3-NP administration (Not specified)
Chronic systemic 3-NP administration (1 month)
Presence and extent of striatal lesions
From paperNot specified in methods section
Artifact type
Endpoint measurements summarized by group or timepoint
Comparison focus
Compare endpoint magnitude between groups, timepoints, or both
Neurochemical markers in spiny projection neurons (GABA, substance P, calbindin)
From paperNot specified in methods section
Artifact type
Endpoint measurements summarized by group or timepoint
Comparison focus
Compare endpoint magnitude between groups, timepoints, or both
Neurochemical markers in aspiny interneurons (somatostatin, neuropeptide Y, NADPH-diaphorase)
From paperNot specified in methods section
Artifact type
Endpoint measurements summarized by group or timepoint
Comparison focus
Compare endpoint magnitude between groups, timepoints, or both
Dopaminergic afferent projection integrity
From paperNot specified in methods section
Artifact type
Endpoint measurements summarized by group or timepoint
Comparison focus
Compare endpoint magnitude between groups, timepoints, or both
Presence and extent of striatal lesions
From paperRaw artifact
Per-sample or per-animal endpoint measurements collected during the experiment
Processed artifact
Structured table with cleaned measurements ready for comparison
Final reported form
Summary statistics and between-group or across-timepoint comparisons
Neurochemical markers in spiny projection neurons (GABA, substance P, calbindin)
From paperRaw artifact
Per-sample or per-animal endpoint measurements collected during the experiment
Processed artifact
Structured table with cleaned measurements ready for comparison
Final reported form
Summary statistics and between-group or across-timepoint comparisons
Neurochemical markers in aspiny interneurons (somatostatin, neuropeptide Y, NADPH-diaphorase)
From paperRaw artifact
Per-sample or per-animal endpoint measurements collected during the experiment
Processed artifact
Structured table with cleaned measurements ready for comparison
Final reported form
Summary statistics and between-group or across-timepoint comparisons
Dopaminergic afferent projection integrity
From paperRaw artifact
Per-sample or per-animal endpoint measurements collected during the experiment
Processed artifact
Structured table with cleaned measurements ready for comparison
Final reported form
Summary statistics and between-group or across-timepoint comparisons
Acquisition
Collect raw experimental outputs with enough metadata to preserve sample identity, condition, and timing.
Preprocessing / cleaning
Not specified in methods section
Scoring or quantification
Quantify the primary readouts for this experiment: Presence and extent of striatal lesions; Neurochemical markers in spiny projection neurons (GABA, substance P, calbindin); Neurochemical markers in aspiny interneurons (somatostatin, neuropeptide Y, NADPH-diaphorase); Dopaminergic afferent projection integrity.
Statistical comparison
Statistical method not yet structured for this page.
Reporting output
Report representative outputs alongside summary comparisons for Presence and extent of striatal lesions, Neurochemical markers in spiny projection neurons (GABA, substance P, calbindin), Neurochemical markers in aspiny interneurons (somatostatin, neuropeptide Y, NADPH-diaphorase), Dopaminergic afferent projection integrity.
Source links and direct wording from the methods section for validation and deeper review.
Citation
MF Beal et al. (1993). Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid. Journal of Neuroscience
“”
“”
“”
“”
Direct vendor pages are linked from the protocol above. This section stays focused on the full comparison view and the prep checklist.
Gather these items before starting the experiment. Check off items as you prepare.
Not specified • Not specified • Not specified • Not specified
Not specified • Not specified • Not specified • Not specified
Not specified • Not specified • Not specified • Not specified
Not specified • Not specified • Not specified • Not specified
Not specified • Not specified • Not specified • Not specified
1 item with ReplicateScience direct pages
Estimated: $187.00
Use this section as the page quality checkpoint. It keeps section navigation, evidence access, readiness, and verification meaning in one place.
Current status surfaces were computed from experiment data updated Feb 28, 2026.
Source access
Jump back into the original paper or the methods evidence section when you need exact wording, exclusions, or method-specific caveats.
This protocol has structured steps plus evidence quotes, and is ready for canonical sync.
Steps
10
Evidence Quotes
15
Protocol Items
5
Linked Products
1
Canonical Sync
Pending
What this means
The completeness score reflects how much structured protocol data is present: steps, methods evidence, listed materials, linked products, and paper provenance.
Computed from the current experiment record updated Feb 28, 2026.
Canonical Sync shows whether a ConductGraph-backed protocol is available for this experiment route right now. It is a sync-status signal, not a claim that every downstream vendor link or step detail is perfect.
Steps
10
Evidence
15
Specific Products
1/1
Canonical Sync
Pending
What this score means
The verification score reflects evidence coverage, subject detail, paper provenance, step depth, and whether linked products resolve to specific item pages instead of generic searches.
Computed from the current experiment record updated Feb 28, 2026.
A page can have structured steps and still need review when evidence is thin, product links are generic, or canonical protocol coverage is still pending.